Search - tctmd.com

Displaying 201 - 220 of 1081

Sort: Relevancy | Date

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Conference News ESC 2022

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

Todd Neale

August 27, 2022

News Conference News ESC 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

L.A. McKeown

August 27, 2022

News Industry News

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

July 20, 2022

News Daily News

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

Yael L. Maxwell

July 01, 2022

News Features

Climate Cardiology: If Not Now, When?

Caitlin E. Cox

June 20, 2022

News Daily News

LAA Occlusion With Watchman Provides Good Early Results in China

Todd Neale

June 07, 2022

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News ESC Heart Failure 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Shelley Wood

May 23, 2022

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Shelley Wood

May 22, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Daily News

New CAC Risk Tool Helps Contextualize Scores for Younger Adults

Yael L. Maxwell

May 12, 2022

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

Advertisement

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

New Faces, New Formats, New Tech: What to Expect From TCT 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

Climate Cardiology: If Not Now, When?

LAA Occlusion With Watchman Provides Good Early Results in China

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Registry Data Hint at MACE Benefit With Renal Denervation

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

New CAC Risk Tool Helps Contextualize Scores for Younger Adults

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content